{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:25:51Z","timestamp":1761708351414},"reference-count":105,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jpsychires.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T08:36:26Z","timestamp":1240562186000},"page":"1095-1105","source":"Crossref","is-referenced-by-count":25,"title":["Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia"],"prefix":"10.1016","volume":"43","author":[{"given":"Hans-Gert","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresia","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Lendeckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Bukowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Ansorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Stauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Ten","family":"Have","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2009.03.006_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/bjp.184.5.383","article-title":"Foetal origins of schizophrenia: testable hypotheses of genetic and environmental influences","volume":"184","author":"Abel","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1515\/CCLM.2007.265","article-title":"Associations of blood levels of insulin-like factor (IGF)-I, IGF-II and IGF binding protein (GFBP)-3 in schizophrenic Arab subjects","volume":"45","author":"Akanji","year":"2007","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2008.172","article-title":"Target identification for CNS diseases by transcriptional profiling","author":"Altar","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib4","first-page":"29","article-title":"The insulin and glucagon degrading proteinase of rat liver. Separation of the proteinase from the thiol proteindisulfide oxidoreductase","volume":"43","author":"Ansorge","year":"1984","journal-title":"Biomedica et Biochimica Acta"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib5","first-page":"39","article-title":"The insulin-and glucagon degrading proteinase of rat liver: a metal dependent enzyme","volume":"43","author":"Ansorge","year":"1984","journal-title":"Biomedica et Biochimica Acta"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib6","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clinical and Investigative Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib7","first-page":"321","article-title":"Rat brain insulin-degrading enzyme in insulin and thyroid imbalances","volume":"21","author":"Azam","year":"1990","journal-title":"Biochemistry International"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0076-6879(95)48046-3","article-title":"The rat insulin-degrading enzyme of mammals and bacteria","volume":"248","author":"Baumeister","year":"1995","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1749-6632.2000.tb06733.x","article-title":"Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia","volume":"911","author":"Benes","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1006\/bbrc.1994.2034","article-title":"Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase","volume":"202","author":"Bennett","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib11","series-title":"Proteases in the brain","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/0-387-23101-3_1","article-title":"Proteases and Alzheimer\u00b4s disease: present knowledge and emerging concepts of therapy","author":"Bernstein","year":"2005"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00461-2","article-title":"Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics","volume":"83","author":"Bernstein","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer\u00b4s disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1007056731551","article-title":"Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and vilip-3) in human brain","volume":"28","author":"Bernstein","year":"1999","journal-title":"Journal of Neurocytology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/A:1016520932139","article-title":"Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia","volume":"30","author":"Bernstein","year":"2001","journal-title":"Journal of Neurocytology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib16","first-page":"OL259","article-title":"Fewer beta-endorphin expressing arcuate nucleus neurons and reduced beta-endorphinergic innervation of paraventricular neurons in schizophrenics and patients with depression","volume":"48","author":"Bernstein","year":"2002","journal-title":"Cellular and Molecular Biology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2007.05.038","article-title":"A reduced number of cortical neurons show increased caldendrin protein levels in chronic schizophrenia","volume":"96","author":"Bernstein","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jchemneu.2007.12.001","article-title":"Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary","volume":"35","author":"Bernstein","year":"2008","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.psyneuen.2007.12.002","article-title":"Beacon-like\/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia","volume":"33","author":"Bernstein","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/hmg\/ddn005","article-title":"Dyregulation of miRNA 181b in the temporal cortex in schizophrenia","volume":"17","author":"Beveridge","year":"2008","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00018-005-5353-3","article-title":"Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation","volume":"63","author":"Bukowska","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"Suppl. 2","key":"10.1016\/j.jpsychires.2009.03.006_bib22","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1211\/jpp.59.1.0013","article-title":"Shifts in metabolic parameters surrounding glucose homeostasis resulting from tricyclic antidepressant therapy: implications of insulin resistance?","volume":"59","author":"Chadwick","year":"2007","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(89)90615-8","article-title":"Chronic haloperidol treatment with low doses may enhance the increase of homovanillic acid in rat brain","volume":"62","author":"Chang","year":"1989","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0197-4580(84)90035-6","article-title":"Stability of neuronal number in the human nucleus basalis of meynert with age","volume":"5","author":"Chui","year":"1984","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.neubiorev.2007.04.004","article-title":"Molecular connexions between dementia and diabetes","volume":"31","author":"Cole","year":"2007","journal-title":"Neuroscience Biobehavioral Reviews"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in later-onset Alzheimer\u00b4s disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1365-2990.2005.00674.x","article-title":"Attenuation of Abeta deposition in the entorhinal cortex of normal eldery individuals associated with tobacco smoking","volume":"31","author":"Court","year":"2005","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-9964(02)00307-9","article-title":"Volumes of association thalamic nuclei in schizophrenia: a postmortem study","volume":"60","author":"Danos","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mp.4000684","article-title":"Muscarinic 1 and 2 receptor mRNA in human caudate-putamen: no change in m1 mRNA in schizophrenia","volume":"5","author":"Dean","year":"2000","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2008.01.028","article-title":"Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review","volume":"101","author":"De Hert","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer\u00b4s disease","volume":"7","author":"De la Monte","year":"2005","journal-title":"Journal of Alzheimer\u00b4s Disease"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib34","first-page":"281","article-title":"Insulin-degrading enzyme hydrolyzes ATP","author":"Del Carmen Camberos","year":"2007","journal-title":"Experimental Biology and Medicine (Maywood 23)"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1176\/appi.ajp.159.5.803","article-title":"A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder","volume":"159","author":"DeLisi","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00439-007-0358-7","article-title":"Genetic liability to schizophrenia in Oceanic Palau: a search in the affected and maternal generation","volume":"121","author":"Devlin","year":"2007","journal-title":"Human Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ar.1092070108","article-title":"Insulin-and glucagonlike peptides in the brain","volume":"207","author":"Dorn","year":"1983","journal-title":"Anatomical Record"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib38","unstructured":"Diagnostic and statistical manual of mental disorders (3rd ed. revised, DSM-III-R 1987). American Psychiatric Association editor, Washington DC: American Psychiatric Press; p. 1\u2013924."},{"key":"10.1016\/j.jpsychires.2009.03.006_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0006-3223(03)00185-9","article-title":"Selective deficit of hippocampal N-acetylaspartate in antipsychotic-na\u00efve patients with schizophrenia","volume":"54","author":"Fannon","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biopsych.2007.11.023","article-title":"Novel linkage to chromosome 20p using classes of psychotic illness in 270 Irish high-density families","volume":"64","author":"Fanous","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib41","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","article-title":"Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique","volume":"31","author":"Fatemi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sproadic Alzheimer\u00b4s disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2008.40","article-title":"Antipsychotic durg mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway","volume":"13","author":"Girgis","year":"2008","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0920-9964(03)00180-4","article-title":"Do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia?","volume":"67","author":"Gunnell","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.b.30396","article-title":"IGF 1, growth pathway polymorphisms and schizophrenia, a pooling study","volume":"144B","author":"Gunnell","year":"2007","journal-title":"American Journal of Medical Genetics B Neuropsychiatric Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib46","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1006\/jmcc.1999.0970","article-title":"Reduced sarcoplasmic reticulum (Ca2+)-uptake and expression of phospholamban in left ventricular myocardium of dogs with heart failure","volume":"31","author":"Gupta","year":"1999","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.yic.0000188215.84784.17","article-title":"High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia","volume":"21","author":"H\u00e4gg","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib48","doi-asserted-by":"crossref","unstructured":"Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R, et al. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. Acta Psychiatrica Scandinavica, in press. doi:10.1111\/j.1600-0447.2008.01325.x.","DOI":"10.1111\/j.1600-0447.2008.01325.x"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-4943(95)00646-3","article-title":"Desensitization of neuronal insulin receptor: a new approach in the aetiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)?","volume":"21","author":"Henneberg","year":"1995","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib50","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1007\/s00018-006-6238-9","article-title":"The insulysin (insulin degrading enzyme) enigma","volume":"63","author":"Hersh","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1471-4159.1997.68010333.x","article-title":"Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer\u00b4s disease pathology in schizophrenia","volume":"68","author":"Higaki","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib52","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB Journal"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1464-5491.2004.01199.x","article-title":"Schizophrenia the metabolic syndrome and diabetes","volume":"21","author":"Holt","year":"2004","journal-title":"Diabetic Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib54","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddn137","article-title":"Evidence that the gene encoding insulin degrading enzyme influences human lifespan","volume":"17","author":"Hong","year":"2008","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib55","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u00b4s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib56","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1371\/journal.pmed.0030428","article-title":"Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis","volume":"3","author":"Huang","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1078\/0065-1281-00611","article-title":"Lack of neuronal NOS has consequences for the expression of POMC and POMC-derived peptides in the mouse pituitary","volume":"103","author":"Keilhoff","year":"2001","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib58","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1074\/jbc.M609168200","article-title":"Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families","volume":"282","author":"Kim","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib59","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1192\/bjp.184.47.s64","article-title":"Diabetes mellitus and schizophrenia: historical perspective","volume":"184","author":"Kohen","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00406-006-0661-7","article-title":"Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution","volume":"256","author":"Kornhuber","year":"2006","journal-title":"European of Archives Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","article-title":"Alzheimer\u2019s beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme","volume":"345","author":"Kurochkin","year":"1994","journal-title":"FEBS Letters"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib62","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.mp.4001322","article-title":"Genome scan of Arab Israeli families maps a schizophrenia successibility gene to chromosome 6q23 and supports a locus at chromosome 10q24","volume":"8","author":"Lerer","year":"2003","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib63","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuropharm.2006.07.006","article-title":"Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats","volume":"51","author":"Lin","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01191700","article-title":"A review of recent advances in stereology for quantifying neural structure","volume":"21","author":"Mayhew","year":"1992","journal-title":"Journal of Neurocytology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1027325304203","article-title":"Degradation of Alzheimer\u00b4s beta amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme","volume":"22","author":"McDermott","year":"1997","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib66","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-005-0425-y","article-title":"Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes","volume":"113","author":"Mehler-Wex","year":"2006","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u00b4s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib68","doi-asserted-by":"crossref","unstructured":"Mitchell MBD. Editorial: clustering of schizophrenia with other comorbidities \u2013 what can we learn? Schizophrenia Bulletin, 2009 doi:10.1093\/schbul\/sbn189.","DOI":"10.1093\/schbul\/sbn189"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib69","doi-asserted-by":"crossref","first-page":"56004","DOI":"10.1074\/jbc.M407283200","article-title":"Insulin-degrading enzyme in brain microvessels. Proteolysis of amyloid variants and reduced activity in cerebral amyloid angiopathy","volume":"279","author":"Morelli","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib70","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/1096-8628(20001204)96:6<864::AID-AJMG35>3.0.CO;2-D","article-title":"Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample","volume":"96","author":"Mowry","year":"2000","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1432-1033.1991.tb16374.x","article-title":"Atrial natriuretic peptide (ANP) is a highly affinity substrate for rat brain insulin-degrading enzyme","volume":"202","author":"M\u00fcller","year":"1991","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib72","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0021-9258(18)48431-1","article-title":"Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver","volume":"267","author":"Ogawa","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000078823","article-title":"Haloperidol attenuates beta-amyloid-induced calcium imbalance in human fibroblasts","volume":"17","author":"Palotas","year":"2004","journal-title":"Skin Pharmacology and Physiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid beta-peptides1-40, 1-42, and Dutch variant 1-40Q by insulin-degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"Perez","year":"2000","journal-title":"Neurochemistry Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2008.09.028","article-title":"Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-na\u00efve population","volume":"107","author":"Perez-Iglesias","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.1996.01830020055007","article-title":"Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression","volume":"53","author":"Purba","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib77","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin insulin-degrading enzyme and amyloid-beta peptide in Alzheimer\u00b4s disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib78","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2826.2008.01705.x","article-title":"Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid","volume":"20","author":"Reed","year":"2008","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-1281(87)80047-8","article-title":"Proteolytic degradation of insulin and glucagon in rat brain during ontogenesis","volume":"82","author":"Reiser","year":"1987","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib80","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.160.5.867","article-title":"Amyloid beta pathology in Alzheimer\u00b4s disease and schizophrenia","volume":"160","author":"Religa","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/07435808409035411","article-title":"Degradation of insulin-like growth factors I and II by a human insulin-degrading enzyme","volume":"10","author":"Roth","year":"2003","journal-title":"Endocrine Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/diabetes.28.4.324","article-title":"The effect of age on insulin degrading enzyme activity in rat tissue","volume":"28","author":"Runyan","year":"1979","journal-title":"Diabetes"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib83","first-page":"3","article-title":"Metabolic syndrome: epidemiology and consequences","volume":"18","author":"Sacks","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib84","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1021\/bi960582q","article-title":"Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme","volume":"35","author":"Safavi","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(03)00154-0","article-title":"Non-covalent interaction of ubiquitin with insulin-degrading enzyme","volume":"204","author":"Saric","year":"2003","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib86","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archpsyc.60.1.69","article-title":"Regional specificity in the neuronal substrates of schizophrenia: a morphometric analysis of Broca\u00b4s area 44 and area 9","volume":"60","author":"Selemon","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib87","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.jnen.0000235853.70092.ba","article-title":"Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology","volume":"65","author":"Sigurdsson","year":"2006","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib88","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuint.2006.03.009","article-title":"Density of Sgt-1 immunopositive neurons is decreased in the cerebral cortex of Alzheimer\u00b4s disease brain","volume":"49","author":"Spiechowicz","year":"2006","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib89","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archpsyc.1992.01820070016003","article-title":"Limbic system abnormalities in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome","volume":"49","author":"Tamminga","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.ijo.0801840","article-title":"Increased visceral fat distribution in drug-na\u00efve and drug-free patients with schizophrenia","volume":"26","author":"Thakore","year":"2002","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"issue":"Suppl. 47","key":"10.1016\/j.jpsychires.2009.03.006_bib91","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1192\/bjp.184.47.s76","article-title":"Metabolic disturbances in first-episode schizophrenia","author":"Thakore","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib92","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10398560701636906","article-title":"Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders","volume":"15","author":"Tirupati","year":"2007","journal-title":"Australasian Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","article-title":"Insulin signaling in the central nervous system: learning to survive","volume":"79","author":"Van der Heide","year":"2006","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib94","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-na\u00efve schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib95","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib96","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmg.2006.048470","article-title":"Insulin-degrading enzyme is genetically associated with Alzheimer\u00b4s disease in the Finnish population","volume":"44","author":"Veps\u00e4l\u00e4inen","year":"2007","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000122267","article-title":"Increased plasma leptin in antipsychotic-na\u00efve females with schizophrenia, but not in males","volume":"56","author":"Wang","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib99","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/0024-3205(88)90039-2","article-title":"Increased concentration of alpha-and gamma-endorphin in postmortem hypothalamic tissue of schizophrenic patients","volume":"42","author":"Wiegant","year":"1988","journal-title":"Life Sciences"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0006-3223(98)00331-X","article-title":"Cell biology of the hippocampal formation in schizophrenia","volume":"45","author":"Weinberger","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib101","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/380206","article-title":"A systematic genomwide linkage analysis study in 353 sib pairs with schizophrenia","volume":"73","author":"Williams","year":"2003","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib102","first-page":"421","article-title":"Expression of the metalloprotease insulin-degrading enzyme in normal and malignant human tissues","volume":"22","author":"Yfanti","year":"2008","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib103","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2990.1999.00183.x","article-title":"Intracranial cavity volume can be accurately estimated from the weights of intracranial contents: confirmation by the dental plaster casting method","volume":"25","author":"Yamada","year":"1999","journal-title":"Neuropathology and Applied Neurobiology"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib104","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as downstream target of insulin receptor signaling cascade: implications for Alzheimer\u00b4s disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jpsychires.2009.03.006_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.02.009","article-title":"Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction","volume":"84","author":"Zhao","year":"2007","journal-title":"Schizophrenia Research"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395609000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395609000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T13:06:36Z","timestamp":1633352796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395609000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":105,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0022395609000570"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2009.03.006","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}